Biosimilars – Increasing Patient Care By Enhancing The Pharmacist’s Role – Ordre des pharmaciens du Québec (OPQ)

Upon completion of this program, participants will be able to:

• Distinguish the difference between biosimilars and generic agents.
• Discuss the safety, efficacy, clinical role and opportunity of biosimilar insulins with patients and healthcare professionals.
• Recognize the pharmacokinetics, clinical considerations and applications of biosimilar insulins.
• Recommend, dispense, and prescribe biosimilar insulins (where applicable).